BMC Genomics,
Journal Year:
2022,
Volume and Issue:
23(1)
Published: Feb. 15, 2022
The
collective
of
somatic
mutations
in
a
genome
represents
record
mutational
processes
that
have
been
operative
cell.
These
can
be
investigated
by
extracting
relevant
patterns
from
sequencing
data.
Molecular Cancer,
Journal Year:
2020,
Volume and Issue:
19(1)
Published: March 12, 2020
The
epigenetic
regulation
of
immune
response
has
been
demonstrated
in
recent
studies.
Nonetheless,
potential
roles
RNA
N6-methyladenosine
(m6A)
modification
tumor
microenvironment
(TME)
cell
infiltration
remain
unknown.We
comprehensively
evaluated
the
m6A
patterns
1938
gastric
cancer
samples
based
on
21
regulators,
and
systematically
correlated
these
with
TME
cell-infiltrating
characteristics.
m6Ascore
was
constructed
to
quantify
individual
tumors
using
principal
component
analysis
algorithms.Three
distinct
were
determined.
characteristics
under
three
highly
consistent
phenotypes
including
immune-excluded,
immune-inflamed
immune-desert
phenotypes.
We
evaluation
within
could
predict
stages
inflammation,
subtypes,
stromal
activity,
genetic
variation,
patient
prognosis.
Low
m6Ascore,
characterized
by
increased
mutation
burden
activation
immunity,
indicated
an
inflamed
phenotype,
69.4%
5-year
survival.
Activation
stroma
lack
effective
observed
high
subtype,
indicating
a
non-inflamed
immune-exclusion
poorer
also
linked
neoantigen
load
enhanced
anti-PD-1/L1
immunotherapy.
Two
immunotherapy
cohorts
confirmed
patients
lower
significant
therapeutic
advantages
clinical
benefits.This
work
revealed
played
nonnegligible
role
formation
diversity
complexity.
Evaluating
pattern
will
contribute
enhancing
our
cognition
characterization
guiding
more
strategies.
Frontiers in Immunology,
Journal Year:
2021,
Volume and Issue:
12
Published: July 2, 2021
Recent
advances
in
next-generation
sequencing
(NGS)
technologies
have
triggered
the
rapid
accumulation
of
publicly
available
multi-omics
datasets.
The
application
integrated
omics
to
explore
robust
signatures
for
clinical
translation
is
increasingly
emphasized,
and
this
attributed
success
immune
checkpoint
blockades
diverse
malignancies.
However,
effective
tools
comprehensively
interpreting
data
are
still
warranted
provide
increased
granularity
into
intrinsic
mechanism
oncogenesis
immunotherapeutic
sensitivity.
Therefore,
we
developed
a
computational
tool
Immuno-Oncology
Biological
Research
(IOBR),
providing
comprehensive
investigation
estimation
reported
or
user-built
signatures,
TME
deconvolution,
signature
construction
based
on
data.
Notably,
IOBR
offers
batch
analyses
these
their
correlations
with
phenotypes,
long
non-coding
RNA
(lncRNA)
profiling,
genomic
characteristics,
generated
from
single-cell
(scRNA-seq)
different
cancer
settings.
Additionally,
integrates
multiple
existing
microenvironmental
deconvolution
methodologies
convenient
comparison
selection.
Collectively,
user-friendly
leveraging
facilitate
immuno-oncology
exploration
unveil
tumor-immune
interactions
accelerating
precision
immunotherapy.
Cell,
Journal Year:
2020,
Volume and Issue:
183(5), P. 1436 - 1456.e31
Published: Nov. 1, 2020
The
integration
of
mass
spectrometry-based
proteomics
with
next-generation
DNA
and
RNA
sequencing
profiles
tumors
more
comprehensively.
Here
this
"proteogenomics"
approach
was
applied
to
122
treatment-naive
primary
breast
cancers
accrued
preserve
post-translational
modifications,
including
protein
phosphorylation
acetylation.
Proteogenomics
challenged
standard
cancer
diagnoses,
provided
detailed
analysis
the
ERBB2
amplicon,
defined
tumor
subsets
that
could
benefit
from
immune
checkpoint
therapy,
allowed
accurate
assessment
Rb
status
for
prediction
CDK4/6
inhibitor
responsiveness.
Phosphoproteomics
uncovered
novel
associations
between
suppressor
loss
targetable
kinases.
Acetylproteome
highlighted
acetylation
on
key
nuclear
proteins
involved
in
damage
response
revealed
cross-talk
cytoplasmic
mitochondrial
metabolism.
Our
results
underscore
potential
proteogenomics
clinical
investigation
through
annotation
pathways
biological
features
remarkably
heterogeneous
malignancy.
Nature Communications,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: April 14, 2021
Abstract
Breast
cancer
is
a
heterogeneous
pathology,
but
the
genomic
basis
of
its
variability
remains
poorly
understood
in
populations
other
than
Caucasians.
Here,
through
DNA
and
RNA
portraits
we
explored
molecular
features
breast
cancers
set
Hispanic-Mexican
(HM)
women
compared
them
to
public
multi-ancestry
datasets.
HM
patients
present
an
earlier
onset
disease,
particularly
aggressive
clinical
subtypes,
non-Hispanic
women.
The
age-related
COSMIC
signature
1
was
more
frequent
those
from
ancestries.
We
found
AKT1
E17K
hotspot
mutation
8%
identify
AKT1/PIK3CA
axis
as
potentially
druggable
target.
Also,
luminal
tumors
enhanced
immunogenic
phenotype
Asiatic
Caucasian
tumors.
This
study
initial
effort
include
Hispanic
research
etiology
biology
further
understand
disparities.
Cell,
Journal Year:
2020,
Volume and Issue:
182(1), P. 226 - 244.e17
Published: July 1, 2020
Lung
cancer
in
East
Asia
is
characterized
by
a
high
percentage
of
never-smokers,
early
onset
and
predominant
EGFR
mutations.
To
illuminate
the
molecular
phenotype
this
demographically
distinct
disease,
we
performed
deep
comprehensive
proteogenomic
study
on
prospectively
collected
cohort
Taiwan,
representing
stage,
predominantly
female,
non-smoking
lung
adenocarcinoma.
Integrated
genomic,
proteomic,
phosphoproteomic
analysis
delineated
attributes
hallmarks
tumor
progression.
Mutational
signature
revealed
age-
gender-related
mutagenesis
mechanisms,
prevalence
APOBEC
mutational
younger
females
over-representation
environmental
carcinogen-like
signatures
older
females.
A
proteomics-informed
classification
distinguished
clinical
characteristics
stage
patients
with
Furthermore,
integrated
protein
network
cellular
remodeling
underpinning
trajectories
nominated
candidate
biomarkers
for
patient
stratification
therapeutic
intervention.
This
multi-omic
architecture
may
help
develop
strategies
management
never-smoker
International Journal of Surgery,
Journal Year:
2022,
Volume and Issue:
107, P. 106936 - 106936
Published: Sept. 20, 2022
Postoperative
progression
and
chemotherapy
resistance
is
the
major
cause
of
treatment
failure
in
patients
with
triple-negative
breast
cancer
(TNBC).
Currently,
there
a
lack
an
ideal
predictive
model
for
drug
sensitivity
postoperative
TNBC
patients.
Diverse
programmed
cell
death
(PCD)
patterns
play
important
role
tumor
progression,
which
has
potential
to
be
prognostic
indicator
after
surgery.Twelve
PCD
(apoptosis,
necroptosis,
pyroptosis,
ferroptosis,
cuproptosis,
entotic
death,
netotic
parthanatos,
lysosome-dependent
autophagy-dependent
alkaliptosis,
oxeiptosis)
were
analyzed
construction.
Bulk
transcriptome,
single-cell
genomics,
clinical
information
collected
from
TCGA-BRCA,
METABRIC,
GSE58812,
GSE21653,
GSE176078,
GSE75688,
KM-plotter
cohorts
validate
model.The
machine
learning
algorithm
established
index
(CDI)
12-gene
signature.
Validated
five
independent
datasets,
high
CDI
had
worse
prognosis
surgery.
Two
molecular
subtypes
distinct
vital
biological
processes
identified
by
unsupervised
clustering
model.
A
nomogram
performance
was
constructed
incorporating
features.
Furthermore,
associated
immune
checkpoint
genes
key
microenvironment
components
integrated
analysis
bulk
transcriptome.
are
resistant
standard
adjuvant
regimens
(docetaxel,
oxaliplatin,
etc.);
however,
they
might
sensitive
palbociclib
(an
FDA-approved
luminal
cancer).Generally,
we
novel
comprehensively
analyzing
diverse
patterns,
can
accurately
predict
user-friendly
website
created
facilitate
application
this
prediction
(https://tnbc.shinyapps.io/CDI_Model/).
Genes,
Journal Year:
2022,
Volume and Issue:
13(5), P. 851 - 851
Published: May 10, 2022
Clear
cell
renal
carcinoma
(ccRCC)
is
the
most
prevalent
subtype
of
carcinoma,
which
characterized
by
metabolic
reprogramming.
Cuproptosis,
a
novel
form
death,
highly
linked
to
mitochondrial
metabolism
and
mediated
protein
lipoylation.
However,
clinical
impacts
cuproptosis-related
genes
(CRGs)
in
ccRCC
largely
remain
unclear.
In
current
study,
we
systematically
evaluated
genetic
alterations
ccRCC.
Our
results
revealed
that
CDKN2A,
DLAT,
DLD,
FDX1,
GLS,
PDHA1
PDHB
exhibited
differential
expression
between
normal
tissues
(|log2(fold
change)|
>
2/3
p
<
0.05).
Utilizing
an
iterative
sure
independence
screening
(SIS)
method,
separately
constructed
prognostic
signature
CRGs
for
predicting
overall
survival
(OS)
progression-free
(PFS)
patients.
The
score
yielded
area
under
curve
(AUC)
0.658
0.682
prediction
5-year
OS
PFS,
respectively.
Kaplan−Meier
analysis
OS,
higher
risk
gene
was
significantly
correlated
with
worse
(HR
=
2.72
(2.01−3.68),
log-rank
1.76
×
10−7).
Patients
had
shorter
PFS
2.83
(2.08−3.85),
3.66
Two
independent
validation
datasets
(GSE40435
(N
101),
GSE53757
72))
were
collected
meta-analysis,
suggesting
CDKN2A
(log2(fold
change)
1.46,
95%CI:
1.75−2.35)
showed
while
DLAT
−0.54,
−0.93−−0.15)
FDX1
−1.01,
−1.61−−0.42)
lowly
expressed.
also
associated
immune
infiltration
levels
programmed
death
1
(PD-1)
(CDKN2A:
r
0.24,
2.14
10−8;
FDX1:
−0.17,
1.37
10−4).
conclusion,
could
serve
as
potential
predictor
patients
may
offer
insights
into
cancer
treatment.